Tadamitsu Kishimoto
9Patents
0Active
9Granted
28Portfolio score
Filing activity: Oct 22, 1990 → Feb 25, 2004
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5888510A | Chronic rheumatoid arthritis therapy containing IL-6 antagonist as effective component | Emerging Cross-Sectional Technologies | 200 | Expired |
| US6277832A | Growth inhibitor for leukemia cells comprising antisense oligonucleotide derivative to wilms tumor gene (wt1) | Chemistry; Metallurgy | 35 | Expired |
| US6034235A | Growth inhibitor for leukemia cell comprising antisense oligonucleotide derivative to wilms tumor gene (WT1) | Chemistry; Metallurgy | 31 | Expired |
| US5215892A | C/EBP2 gene and recombinant C/EBP2 | Chemistry; Metallurgy | 6 | Expired |
| US5362489A | Use of recombinant B-cell differentiation factor for augmenting antibody production and stimulating bone marrow proliferation | Chemistry; Metallurgy | 4 | Expired |
| US8119126B2 | Inhibiting vascularization using antibodies to CXCR4 and SDF-1 | Human Necessities | 4 | Expired |
| US5360894A | C/EBP2 gene and recombinant C/EBP2 | Chemistry; Metallurgy | 3 | Expired |
| US5541088A | Recombinant process of producing non-glycosylated B-cell defferentiation factor | Chemistry; Metallurgy | 3 | Expired |
| US7247424B2 | Screening method for a substance having hypoglycemic activity by using STAT-induced inhibitor of STAT function-1 | Physics | 0 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.